2nd Circ. Tosses Apotex's False Ad Row Over MS Drug
Two New York federal judges rightly threw out Apotex Inc.'s case accusing Acorda Therapeutics Inc. of making false and misleading statements about Zanaflex to monopolize the market for its multiple sclerosis...To view the full article, register now.
Already a subscriber? Click here to view full article